Poster

Extracellular Vesicles: Engineering New Therapeutic Delivery Modalities

Source: Lonza
GettyImages-1288978528 Scientist Using Microscope In Lab

Extracellular Vesicles (EVs), particularly exosomes, are gaining traction as natural, nanoscale platforms for delivering therapeutic cargo like nucleic acids, proteins, and small molecules. However, precisely engineering EVs has proven difficult. These complex techniques have also been largely out of reach for many researchers due to their technical hurdles. This discussion will delve into materials and methods for expressing biomolecules directly on EVs.

The development of protein scaffolds offers a clinically validated approach to effectively load therapeutic proteins onto the surface or inside EVs. Additionally, chemical linkers have been designed to attach nucleic acids or small molecules to the EV membrane, ensuring the bioactivity and potency of the cargo remains intact. Case studies and clinical data will be presented to illustrate the effectiveness of each EV loading and linking technology.

To promote broader access, the technologies described here will be made available to research institutions, pharmaceutical companies, and biotechnology firms under a research license. Additionally, these technologies will be available to therapeutics companies through contract development and manufacturing services, allowing them to produce their own engineered EVs.

access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma